| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/13/2003 | EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists |
| 08/13/2003 | EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 08/13/2003 | EP0945435B1 Novel pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient |
| 08/13/2003 | CN1117735C Process for extracting purified isoliensinine and liensinine from plumula nelumbinis |
| 08/13/2003 | CN1117734C Process for extracting lotucine from plumula nelumbinis |
| 08/12/2003 | US6605722 Tyrosine derivatives with anti-leukotrienen activity |
| 08/12/2003 | US6605616 Autoimmune diseases; inflammation |
| 08/12/2003 | US6605615 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
| 08/07/2003 | WO2003064412A1 Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof |
| 08/07/2003 | WO2003064393A1 Thio-carbostyril derivative, its n-oxides and the n-oxides of aripiprazole |
| 08/07/2003 | WO2003064392A1 Process for the manufacture of hmg-coa reductase inhibitors |
| 08/07/2003 | WO2003064382A2 Process for the manufacture of organic compounds |
| 08/07/2003 | WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 08/07/2003 | US20030149108 Linked biaryl compounds |
| 08/07/2003 | US20030149074 Modulators of phosphoinositide 3-kinase |
| 08/07/2003 | US20030149056 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases |
| 08/07/2003 | US20030149052 Side effect reduction |
| 08/07/2003 | US20030149035 For therapy and prophylaxis of infections by herpesviruses |
| 08/07/2003 | US20030149021 For therapy of cancer, as antibacterial, as insecticide |
| 08/07/2003 | US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system |
| 08/07/2003 | US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system |
| 08/07/2003 | CA2472340A1 Process for the manufacture of organic compounds |
| 08/06/2003 | EP1332133A1 Metabotropic glutamate receptor antagonists |
| 08/06/2003 | EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 08/06/2003 | EP0918747B1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF |
| 08/06/2003 | EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists |
| 08/06/2003 | CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives |
| 08/06/2003 | CN1434819A 4-phenyl-peiperazinyl,-piperidinyl and -Tetrahydropyridyl derivatives |
| 08/06/2003 | CN1434816A Novel compounds |
| 08/06/2003 | CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors |
| 08/06/2003 | CN1117080C Method for producing (hetero) aromatic hydroxylamines |
| 08/06/2003 | CN1117071C Pesticides |
| 08/06/2003 | CN1117070C Aryl or heteroaryl amides of tetrahydronahpthalene, chroman, thiochroman and 1,2,3-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 08/05/2003 | US6603012 RAR selective retinoid agonists |
| 08/05/2003 | US6602882 Quinoline derivatives and their use as antibacterial agents |
| 08/05/2003 | CA2275827C Method for treating glaucoma |
| 08/05/2003 | CA2113349C Method of producing a quinolonecarboxylic acid derivative |
| 07/31/2003 | WO2003063555A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/31/2003 | WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 07/31/2003 | WO2003062203A1 Method |
| 07/31/2003 | WO2003062202A2 Method for the production of substituted 1,2,3,4-tetrahydroisoquinoline-2-carboxylic acids |
| 07/31/2003 | WO2003042180A9 Process for producing optically active oxoheptenoic acid ester |
| 07/31/2003 | WO2002062762A3 Potassium channel openers |
| 07/31/2003 | WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030144517 Chiral fluoroquinolone arginine salt forms |
| 07/31/2003 | US20030144507 Sulfonamide-containing heterocyclic compounds |
| 07/31/2003 | US20030144342 alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 07/31/2003 | US20030144323 Phenylalkynes |
| 07/31/2003 | US20030144321 Antitumor agents |
| 07/31/2003 | US20030144284 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |
| 07/31/2003 | US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 07/31/2003 | US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 07/31/2003 | US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis |
| 07/31/2003 | CA2473796A1 Substituted quinazolin-4-ylamine analogues |
| 07/31/2003 | CA2473386A1 Method |
| 07/31/2003 | CA2455844A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/30/2003 | EP1330438A1 Agrochemical composition |
| 07/30/2003 | EP1330249A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 07/30/2003 | EP1187817B1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/30/2003 | EP0705100B1 Therapeutic substituted guanidines |
| 07/30/2003 | CN1116296C Benzo [C] quinolizine derivatives, their preparation and use as 5' alpha'-reductases inhibitors |
| 07/30/2003 | CN1116277C Process for preparing carbocylic or heterocyclic nitriles by vapor phase ammoxidation |
| 07/29/2003 | US6600045 This invention relates to methods for preparing certain cholesteryl ester transfer protein (CETP) inhibitors and intermediates useful in the preparation of said CETP inhibitors. |
| 07/29/2003 | US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 07/29/2003 | CA2114136C Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| 07/24/2003 | WO2003059889A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139498 Coloring plastics |
| 07/24/2003 | US20030139445 Method for treating retroviral infections |
| 07/24/2003 | US20030139431 Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors |
| 07/24/2003 | US20030139400 Controlling cell differentiation; antiinflammatory agents |
| 07/24/2003 | US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 07/24/2003 | US20030139390 Compounds for the modulation of PPARgamma activity |
| 07/24/2003 | US20030139388 Antiinflammatory agents; osteoporosis |
| 07/24/2003 | US20030138664 Light emitting device material, light emitting device using thereof, and amine compound |
| 07/24/2003 | CA2700690A1 Process for producing reformatsky reagent in stable form |
| 07/23/2003 | EP1328499A2 Method of producing carboxylic acid salts |
| 07/23/2003 | CN1432001A 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/23/2003 | CN1432000A TNF-alpha prodn. inhibitors |
| 07/23/2003 | CN1431203A 7-substitution-1-hero hydrogenated-2-ketone and ramification as well as its synthesizing method and usage |
| 07/23/2003 | CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 07/23/2003 | CN1115325C Method for synthesis of pyrethrin by catalytic esterification of 4-dimethylaminopyridine |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596522 Compositions and optical methods for determining transmembrane potentials across plasma membrane of biological cells |
| 07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | WO2003057225A2 Phosphate transport inhibitors |
| 07/17/2003 | WO2003039488A3 A method for treating inflammatory bowel disease |
| 07/17/2003 | WO2002099124A3 Characterising polypeptides |
| 07/17/2003 | US20030135044 Novel gamma secretase inhibitors |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | CA2471760A1 Preventives/remedies for urinary disturbance |
| 07/16/2003 | EP1326865A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 07/16/2003 | EP1326842A1 Arylpiperazine derivatives and their use as psychotropic agents |
| 07/16/2003 | EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis |
| 07/16/2003 | EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326834A2 2-substituted heterocyclic compounds |
| 07/16/2003 | EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326824A1 Pharmaceutical compounds |